Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

H Bootsma

Showing results (11-20 of 110) with videos related to

Pageof 11
Sort By:
Nederlands Tijdschrift Voor Tandheelkunde|February 11, 2004
[Swelling of lips as a first sign of acromegaly]A Vissink, F K Spijkervet, H Bootsma, et al.
British Journal of Rheumatology|July 1, 1994
A new class of lupus nephropathy associated with antiphospholipid antibodiesP E Spronk, H Bootsma, P G Nikkels, et al.
Nederlands Tijdschrift Voor Geneeskunde|September 27, 2000
[Relation between ethnicity and reason for referral of new patients to the Internal Medicine outpatient clinic of the Academic Hospital Rotterdam-Dijkzigt, 1997]D R Manna, A H Bootsma, S W Lamberts, et al.
Expert Review of Clinical Immunology|November 13, 2023
At the cutting-edge: what's the latest in imaging to diagnose Sjögren's disease?A Vissink, M S van Ginkel, H Bootsma, et al.
Arthritis and Rheumatism|October 31, 2012
Toward new classification criteria for Sjögren's syndrome?H Bootsma, F K L Spijkervet, F G M Kroese, et al.
Annals of the Rheumatic Diseases|January 14, 2009
Treatment of primary Sjogren syndrome with rituximab: extended follow-up, safety and efficacy of retreatmentJ M Meijer, J Pijpe, A Vissink, et al.
Diabetes Care|July 29, 2006
Normotensive women with type 2 diabetes and microalbuminuria are at high risk for macrovascular diseaseAdrienne A M Zandbergen, Eric J Sijbrands, Steven W Lamberts, et al.
Annals of the Rheumatic Diseases|May 22, 2003
Mycophenolate mofetil prevents a clinical relapse in patients with systemic lupus erythematosus at riskM Bijl, G Horst, H Bootsma, et al.
Diabetes Care|May 27, 2004
Atorvastatin decreases apolipoprotein C-III in apolipoprotein B-containing lipoprotein and HDL in type 2 diabetes: a potential mechanism to lower plasma triglyceridesGeesje M Dallinga-Thie, Ingrid I L Berk-Planken, Aart H Bootsma, et al.
Lupus|August 11, 2006
Quantitation of autoantibodies in systemic autoimmune diseases: clinically useful?C G M Kallenberg, C A Stegeman, H Bootsma, et al.
Pageof 11

Showing results (11-20 of 110) with videos related to

Sort By:
Pageof 11
Nederlands Tijdschrift Voor Tandheelkunde|February 11, 2004
[Swelling of lips as a first sign of acromegaly]A Vissink, F K Spijkervet, H Bootsma, et al.
British Journal of Rheumatology|July 1, 1994
A new class of lupus nephropathy associated with antiphospholipid antibodiesP E Spronk, H Bootsma, P G Nikkels, et al.
Nederlands Tijdschrift Voor Geneeskunde|September 27, 2000
[Relation between ethnicity and reason for referral of new patients to the Internal Medicine outpatient clinic of the Academic Hospital Rotterdam-Dijkzigt, 1997]D R Manna, A H Bootsma, S W Lamberts, et al.
Expert Review of Clinical Immunology|November 13, 2023
At the cutting-edge: what's the latest in imaging to diagnose Sjögren's disease?A Vissink, M S van Ginkel, H Bootsma, et al.
Arthritis and Rheumatism|October 31, 2012
Toward new classification criteria for Sjögren's syndrome?H Bootsma, F K L Spijkervet, F G M Kroese, et al.
Annals of the Rheumatic Diseases|January 14, 2009
Treatment of primary Sjogren syndrome with rituximab: extended follow-up, safety and efficacy of retreatmentJ M Meijer, J Pijpe, A Vissink, et al.
Diabetes Care|July 29, 2006
Normotensive women with type 2 diabetes and microalbuminuria are at high risk for macrovascular diseaseAdrienne A M Zandbergen, Eric J Sijbrands, Steven W Lamberts, et al.
Annals of the Rheumatic Diseases|May 22, 2003
Mycophenolate mofetil prevents a clinical relapse in patients with systemic lupus erythematosus at riskM Bijl, G Horst, H Bootsma, et al.
Diabetes Care|May 27, 2004
Atorvastatin decreases apolipoprotein C-III in apolipoprotein B-containing lipoprotein and HDL in type 2 diabetes: a potential mechanism to lower plasma triglyceridesGeesje M Dallinga-Thie, Ingrid I L Berk-Planken, Aart H Bootsma, et al.
Lupus|August 11, 2006
Quantitation of autoantibodies in systemic autoimmune diseases: clinically useful?C G M Kallenberg, C A Stegeman, H Bootsma, et al.
Pageof 11